Health: A new treatment for COPD?
Nature Communications
March 11, 2015
A drug that is currently used to treat osteoarthritis could help to ease the symptoms of chronic obstructive pulmonary disease (COPD) and smoking induced emphysema, suggests a mouse study in Nature Communications.
COPD is a collection of diseases, including emphysema and chronic bronchitis, where the airways become inflamed, causing shortness of breath. It is associated with significant mortality and also increases the risk of developing lung cancer. Macrophages in the alveoli of the lungs play a major role in the progression of emphysema, especially in the case of smokers, and there is currently no treatment.
Masahiko Kurabayashi and colleagues now report that a drug, called alendronate, eases symptoms in a mouse model of COPD. The drug, which only alleviates symptoms if inhaled, appears to selectively target macrophages and trigger them to die. Recent advances in the management of COPD have helped reduce the frequency and severity of symptoms, but new treatments are still very much needed. Alendronate is already in clinical use for metabolic bone disease and it is known to be safe and well-tolerated by users when ingested. The authors hope that the drug will prove a novel, effective, non-invasive and safe treatment option for COPD.
doi: 10.1038/ncomms7332
Research highlights
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 16
Microbiology: DNA analysis indicates origins of the Black DeathNature